Handelsbanken Fonder’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,009
| Closed | -$280K | – | 1571 |
|
|
2022
Q2 | $280K | Hold |
9,009
| – | – | ﹤0.01% | 1364 |
|
|
2022
Q1 | $370K | Hold |
9,009
| – | – | ﹤0.01% | 1399 |
|
|
2021
Q4 | $392K | Hold |
9,009
| – | – | ﹤0.01% | 1503 |
|
|
2021
Q3 | $451K | Hold |
9,009
| – | – | ﹤0.01% | 1421 |
|
|
2021
Q2 | $567K | Buy |
9,009
+1,300
| +17% | +$81.8K | ﹤0.01% | 1288 |
|
|
2021
Q1 | $716K | Hold |
7,709
| – | – | ﹤0.01% | 1008 |
|
|
2020
Q4 | $691K | Hold |
7,709
| – | – | ﹤0.01% | 984 |
|
|
2020
Q3 | $797K | Hold |
7,709
| – | – | 0.01% | 801 |
|
|
2020
Q2 | $610K | Buy |
+7,709
| New | +$610K | 0.01% | 874 |
|